Declan
@Declanfj
Followers
1K
Following
7K
Media
81
Statuses
3K
Pancreatic surgeon and prehabilitation fanatic.
Liverpool, England
Joined August 2015
RT @DrYukselUrun: Exercizumab is real. Aerobic exercise cut colon cancer recurrence + death. It’s time to combine movement with medicine n….
0
47
0
RT @RAPIDI_Trial: An update from RAPID-I on recruitment:. End of June target - 113.Actual recruitment - 115. Let's keep it going! #pancreat….
0
1
0
RT @SyedAAhmad5: Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice @TheLancetEndo https://t.c….
0
4
0
RT @VincGroot: 🚨 New in @AnnalsofSurgery showing ⬆️ survival with routine imaging vs symptomatic follow-up after #pdac resection. 🕵🏼♂️Rou….
0
5
0
RT @RoyalSurrey: First-of-a-kind pilot study from Royal Surrey and @UniOfSurrey finds that exercising during chemotherapy and before surger….
0
5
0
RT @rajibaji1983: @Adam_Frampton1 launching the CONNECT registry to demonstrate prospective outcomes using biodegradable stents in high ris….
0
4
0
RT @walsh_joe: As a Doctor I am held to a standard where “if I didn’t document it, it never happened” . Why is the GMC any different? . If….
0
100
0
RT @docmartin22: Big win for robotic approach in this study of rectal cancer resections:. Robotic vs Laparoscopic Surgery for Middle and Lo….
0
2
0
RT @DrBetofMDPhD: I’ve been in the exercise oncology field for 20 years and for all of that time, the main criticism has been “show me a we….
0
64
0
RT @rajibaji1983: It was a team effort by a fantastic theatre team @BillFawcett. A very rewarding & efficient day of operating @RoyalSurrey….
0
4
0
RT @AaronGoodman33: The fact this was NOT a plenary at ASCO clearly demonstrates pharma’s strong influence over academic oncology in my opi….
0
87
0
RT @VivekSubbiah: 7/ Structured Exercise after Adjuvant Chemotherapy for Colon Cancer #ASCO25 @ASCO @NEJM .
0
4
0
RT @ZhiVenFongMD: If you’re a GI/HPB surgeon/oncologist who couldn’t make it to @ASCO 2025 & trying to scour for its ongoings online like I….
0
29
0
RT @Gio_Marchegiani: 🚨 From @ASCO 2025 . 👉 Preop chemo with PAXG 🆚 mFOLFIRINOX for extending event-free survival (EFS) in resectable or BR….
0
13
0
RT @StefanoCrippa6: 🇮🇹CASSANDRA TRIAL🇮🇹. Phase 3 RCT: Neoadjuvant PAXG vs mFOLFIRINOX in resectable/BR #PDAC . 💥PAXG shows:.✅⬆️EFS.✅⬆️Path….
0
28
0
Important study demonstrating reasonable long term survival and 5 year recurrence free survival of 18% in patients with PDAC with arterial involvement.
✂️ Arterial resection and divestment 🔟 year comparative study . 🇯🇵 Analysis of 200 PDAC + artery . 👗 Divestment (120 cases) most used in first 5 years. 🎖️Last 5 years ⬆️ Neoadjuvant chemo + resection ⬇️ complications 👍 .
1
0
5
RT @AStewart_Wilson: Leave Trent alone if I left my work after 20 years I’d like to think they’ve have a leaving party 🫣.
0
2
0